NO167664C - Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.

Info

Publication number
NO167664C
NO167664C NO882940A NO882940A NO167664C NO 167664 C NO167664 C NO 167664C NO 882940 A NO882940 A NO 882940A NO 882940 A NO882940 A NO 882940A NO 167664 C NO167664 C NO 167664C
Authority
NO
Norway
Prior art keywords
castanosperminesters
glycosides
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO882940A
Other languages
English (en)
Norwegian (no)
Other versions
NO882940D0 (no
NO882940L (no
NO167664B (no
Inventor
Paul S Liu
John K Daniel
Barry L Rhinehart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO882940D0 publication Critical patent/NO882940D0/no
Publication of NO882940L publication Critical patent/NO882940L/no
Publication of NO167664B publication Critical patent/NO167664B/no
Publication of NO167664C publication Critical patent/NO167664C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO882940A 1987-07-02 1988-07-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider. NO167664C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6935187A 1987-07-02 1987-07-02

Publications (4)

Publication Number Publication Date
NO882940D0 NO882940D0 (no) 1988-07-01
NO882940L NO882940L (no) 1989-01-03
NO167664B NO167664B (no) 1991-08-19
NO167664C true NO167664C (no) 1991-11-27

Family

ID=22088386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882940A NO167664C (no) 1987-07-02 1988-07-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.

Country Status (20)

Country Link
EP (1) EP0297534B1 (es)
JP (1) JP2683915B2 (es)
KR (1) KR970002636B1 (es)
CN (2) CN1020609C (es)
AR (1) AR245128A1 (es)
AT (1) ATE116318T1 (es)
AU (1) AU609146B2 (es)
CA (1) CA1315276C (es)
DE (1) DE3852579T2 (es)
DK (1) DK171053B1 (es)
ES (1) ES2068816T3 (es)
FI (1) FI87072C (es)
GR (1) GR3015303T3 (es)
HU (1) HU199470B (es)
IE (1) IE65164B1 (es)
IL (1) IL86928A (es)
NO (1) NO167664C (es)
NZ (1) NZ225198A (es)
PT (1) PT87895B (es)
ZA (1) ZA884587B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis
US5214050A (en) * 1989-10-17 1993-05-25 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
AU628228B2 (en) * 1989-10-17 1992-09-10 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5066807A (en) * 1990-03-12 1991-11-19 Merrell Dow Pharmaceuticals Inc. Process for the preparation of castanospermine
US5028614A (en) * 1990-03-30 1991-07-02 Merrell Dow Pharmaceuticals Inc. Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
US5079254A (en) * 1990-06-04 1992-01-07 Merrell Dow Pharmaceuticals Inc. Derivatives of 6-aminooctahydroindolizinetriol
ES2212292T3 (es) * 1997-05-22 2004-07-16 Aventis Pharmaceuticals Inc. Procedimiento para preparar 6-0-monoesteres de castanospermina.
GB0110832D0 (en) 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
KR20070053229A (ko) * 2004-08-13 2007-05-23 미게닉스 인코포레이티드 헤파드나비리대 감염을 치료 또는 예방하기 위한 조성물 및방법
DE102020212985B3 (de) 2020-10-14 2021-10-21 Danfoss Power Solutions Gmbh & Co. Ohg Hydraulischer ventilblock sowie hydraulikeinheit für geschlossene kreislaufanwendungen

Also Published As

Publication number Publication date
FI87072C (fi) 1992-11-25
EP0297534B1 (en) 1994-12-28
NZ225198A (en) 1989-12-21
DE3852579D1 (de) 1995-02-09
IE65164B1 (en) 1995-10-04
FI87072B (fi) 1992-08-14
NO882940D0 (no) 1988-07-01
ATE116318T1 (de) 1995-01-15
HU199470B (en) 1990-02-28
KR890002147A (ko) 1989-04-08
ES2068816T3 (es) 1995-05-01
NO882940L (no) 1989-01-03
EP0297534A3 (en) 1990-01-10
FI883164A (fi) 1989-01-03
KR970002636B1 (ko) 1997-03-07
DK366888D0 (da) 1988-07-01
CN1020609C (zh) 1993-05-12
FI883164A0 (fi) 1988-07-01
JP2683915B2 (ja) 1997-12-03
CN1065066A (zh) 1992-10-07
GR3015303T3 (en) 1995-06-30
AU1844888A (en) 1989-01-05
JPS6479179A (en) 1989-03-24
DE3852579T2 (de) 1995-05-04
PT87895B (pt) 1995-03-01
CA1315276C (en) 1993-03-30
CN1030418A (zh) 1989-01-18
NO167664B (no) 1991-08-19
IL86928A (en) 1992-08-18
IL86928A0 (en) 1988-11-30
CN1027264C (zh) 1995-01-04
PT87895A (pt) 1989-06-30
EP0297534A2 (en) 1989-01-04
HUT47572A (en) 1989-03-28
AR245128A1 (es) 1993-12-30
AU609146B2 (en) 1991-04-26
DK366888A (da) 1989-01-03
IE882021L (en) 1989-01-02
ZA884587B (en) 1989-03-29
DK171053B1 (da) 1996-05-06

Similar Documents

Publication Publication Date Title
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO157738C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.
NO854942L (no) Fremgangsmaate for fremstilling av terapeutisk aktive, benzotiofener og benzofuraner.
NO871028D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO173060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
NO162860C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzo-(pyrano og tiopyrano)-pyridiner.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
NO862534L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
NO165493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.